Encyclopedia of Cancer

Living Edition
| Editors: Manfred Schwab

Breast Cancer Multistep Development

Living reference work entry
DOI: https://doi.org/10.1007/978-3-642-27841-9_6655-2

Definition

A multistep development of breast cancer involves increasingly abnormal stages during breast cancer progression as illustrated in Fig. 1.

Keywords

Breast Cancer Invasive Carcinoma Inflammatory Breast Cancer Invasive Lobular Carcinoma Contralateral Breast Cancer 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access

References

  1. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57–70PubMedCrossRefGoogle Scholar
  2. Polyak K (2001) On the birth of breast cancer. Biochim Biophys Acta 1552:1–13PubMedGoogle Scholar
  3. Sorlie T, Perou CM, Tibshirani R et al (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 98:10869–10874PubMedPubMedCentralCrossRefGoogle Scholar
  4. Tang P, Hajdu SI, Lyman GH (2007) Ductal carcinoma in situ: a review of recent advances. Curr Opin Obstet Gynecol 19:63–67PubMedCrossRefGoogle Scholar
  5. Tsikitis VL, Chung MA (2006) Biology of ductal carcinoma in situ classification based on biologic potential. Am J Clin Oncol 29:305–310PubMedCrossRefGoogle Scholar
  6. Xu J, Acharya S, Sahin O et al. (2015) 14–3-3ζ turns TGF-β's function from tumor suppressor to metastasis promoter in breast cancer by contextual changes of Smad partners from p53 to Gli2. Cancer Cell 27:177–192.PubMedCrossRefGoogle Scholar

See Also

  1. (2012) Acetylation. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 17. doi:10.1007/978-3-642-16483-5_24Google Scholar
  2. (2012) Allelic loss. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 137. doi:10.1007/978-3-642-16483-5_186Google Scholar
  3. (2012) Basement membrane. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 349. doi:10.1007/978-3-642-16483-5_537Google Scholar
  4. (2012) Carcinoma. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 657. doi:10.1007/978-3-642-16483-5_848Google Scholar
  5. (2012) Chromatin. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 825. doi:10.1007/978-3-642-16483-5_1125Google Scholar
  6. (2012) Deletion. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 1080. doi:10.1007/978-3-642-16483-5_1553Google Scholar
  7. (2012) Differentiation. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 1113. doi:10.1007/978-3-642-16483-5_1616Google Scholar
  8. (2012) Epithelial cell. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, pp 1291–1292. doi:10.1007/978-3-642-16483-5_1958Google Scholar
  9. (2012) Gain-of-function mutation. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 1489. doi:10.1007/978-3-642-16483-5_2303Google Scholar
  10. (2012) Histones. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 1706. doi:10.1007/978-3-642-16483-5_2762Google Scholar
  11. (2012) HER2. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 1678. doi:10.1007/978-3-642-16483-5_2676Google Scholar
  12. (2012) HOX. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 1739. doi:10.1007/978-3-642-16483-5_2819Google Scholar
  13. (2012) Intravasation. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 1901. doi:10.1007/978-3-642-16483-5_3125Google Scholar
  14. (2012) Loss-of-function mutation. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 2076. doi:10.1007/978-3-642-16483-5_3414Google Scholar
  15. (2012) Mutation. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 2412. doi:10.1007/978-3-642-16483-5_3911Google Scholar
  16. (2012) Myoepithelial cells. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 2440. doi:10.1007/978-3-642-16483-5_3943Google Scholar
  17. (2012) P53. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 2747. doi:10.1007/978-3-642-16483-5_4331Google Scholar
  18. (2012) Proliferation. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 3004. doi:10.1007/978-3-642-16483-5_4766Google Scholar
  19. (2012) Proto-oncogenes. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, pp 3107–3108. doi:10.1007/978-3-642-16483-5_6656Google Scholar
  20. (2012) Stroma. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 3541. doi:10.1007/978-3-642-16483-5_5532Google Scholar
  21. (2012) Translocation. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 3773. doi:10.1007/978-3-642-16483-5_5942Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  1. 1.Departments of Molecular and Cellular OncologyThe University of Texas M.D. Anderson Cancer CenterHoustonUSA